Genetic ablation of interferon-γ up-regulates interleukin-1β expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain

Arthritis and Rheumatism

Volumn 44, Issue 10, 2001, Pages 2413-2424

  Guedez, Yajaira B ^a   Whittington, Karen B ^b   Clayton, Jenny L ^c   Joosten, Leo A B ^a   Van De Loo, Fons A J ^b   Van Den Berg, Wim B ^a   Rosloniec, Edward F ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; COLLAGEN TYPE 2; CYTOKINE; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; IMMUNIZATION; INFLAMMATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; SYNOVIOCYTE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ARTHRITIS; CATTLE; COLLAGEN; GENETIC PREDISPOSITION TO DISEASE; INTERFERON TYPE II; INTERLEUKIN-1; MICE; UP-REGULATION;

EID: 0034762869     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E     Document Type: Article

References (66)

1. The human immune response region (HLA-D) and disease susceptibility
2. HLA and disease 1982 - A survey
3. Immunisation against heterologous type II collagen induces arthritis in mice
4. Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule
5. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis
6. Collagen-induced arthritis in DBA/1 mice: Cytokine gene activation following immunization with type II collagen
7. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis
8. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA)
9. Enhanced autoimmune arthritis in IFN-γ receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells
10. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra
11. Treatment with γ-interferon triggers the onset of collagen arthritis in mice
12. The effect of treatment with interferon-γ on type II collagen-induced arthritis
13. Biphasic effect of interferon-γ in murine collagen-induced arthritis
14. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-γ
15. Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-γ
16. High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors
17. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice
18. Type II collagen induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates
19. Collagen-induced arthritis
20. A CD4 cell is capable of transferring suppression of collagen-induced arthritis
21. IL-1 αβ blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation
22. Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction: Effect of in situ blocking in murine antigen- and zymosan-induced arthritis
23. q mice
24. Characterization of recombinant type II collagen: Arthritogenicity and tolerogenicity in DBA/1 mice
25. Collagen induced arthritis in mice: Localization of an arthritogenic determinant to a fragment of the type II collagen molecule
26. Adjuvant-induced arthritis in rats: Evidence that autoimmunity to collagens types I, II, IX, and XI is not involved in the pathogenesis of arthritis
27. Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4
28. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen
29. Serum transfer of collagen induced arthritis in mice
30. Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats
31. Induction of arthritis with monoclonal antibodies to collagen
32. Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57B1/6 normal and beige (Chédiak-Higashi) strains: Evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis
33. Passive transfer of arthritis in mice by human anti-type II collagen antibody
34. Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen
35. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomy-elitis (EAE)
36. Experimental autoimmune thyroiditis (EAT) in mice lacking the IFN-γ receptor gene
37. Endogenous systemic IFN-γ has a protective role against ocular autoimmunity in mice
38. Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-γ
39. Recombinant human interferon γ in the treatment of rheumatoid arthritis: Double blind placebo controlled study
40. Interferon γ in rheumatoid arthritis - A double blind study comparing human recombinant interferon γ with placebo
41. Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished γ interferon production in response to autologous stimulation
42. Reduced production of interferon a and interferon γ in leukocyte cultures from patients with active rheumatoid arthritis
43. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice
44. Interleukin-1 enhances the development of type II collagen-induced arthritis only in susceptible and not in resistant mice
45. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice
46. Interleukin-1 potentiates the development of collagen-induced arthritis in mice
47. Interleukin 1 can act as a B-cell growth and differentiation factor
48. IL-1 as adjuvant: Role of T cells in the augmentation of specific antibody production by recombinant human IL-1α
49. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones
50. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis
51. Interferon γ plays a critical role in induced cell death of effector T cell: A possible third mechanism of self-tolerance
52. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates
53. Genetic susceptibility to murine collagen II autoimmune arthritis: Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci
54. The role of C5 and T-cell receptor Vβ genes in susceptibility to collagen-induced arthritis
55. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis
56. IFN-γ inhibits activation-induced expression of E- and P-selectin on endothelial cells
57. 2 production by IFN-γ in human macrophages
58. IFN-γ and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes
59. Multiple defects of immune cell function in mice with disrupted interferon-γ genes
60. Immune response in mice that lack the interferon-γ receptor
61. IFN-γ receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis: Protective role of endogenous nitric oxide
62. Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury
63. Nitric oxide prevents IL-1β and IFN-γ-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1β-converting enzyme)
64. NF-κB regulates IL-1β transcription through a consensus NF-κB binding site and a nonconsensus CRE-like site
65. Endotoxin-mediated nitric oxide synthesis inhibits IL-1β gene transcription in ANA-1 murine macrophages
66. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced auto-immune encephalomyelitis